Brain Cancer Clinical Trials

Showing 361-380 of 1,466 trials

Phase 2 Clinical Trial of KH617

NCT07138001

To evaluate the efficacy and safety of KH617 for injection in combination with temozolomide versus investigator's choice therapy or KH617 monotherapy for recurrent glioblastoma

Recurrent Glioblastoma

Sichuan Honghe Biotechnology Co., Ltd.60 participantsStarted Aug 2025

Approved For Marketing

Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas

NCT04617002

This is an intermediate-size expanded access protocol to provide ONC201 (dordaviprone) to patients with H3 K27M-mutant and/or midline gliomas who cannot access ONC201 (dordaviprone) through clinical trials.

GliomaH3 K27M

Jazz Pharmaceuticals

Phoenix, Arizona, United States • Los Angeles, California, United States • Orange, California, United States +20 more locations

Phase 2 Clinical Trial of KH617

Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas

Related Searches

Lerapolturev (PVSRIPO) in GBM

Psychological and Psychiatric prOfile in Glioblastoma and Head and Neck Cancer

Pembrolizumab in Treating Patients With Recurrent Glioblastoma

Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma

Glioblastoma Imaging for the Detection of Tumor Progression Using APTw-CEST MRI

Molecular Imaging of Cancer-associated Fibroblasts in Glioblastoma: a FAPI PET/MR Study.

Proton Beam Radiotherapy for Medulloblastoma and Pineoblastoma

A Study of Ad-RTS-hIL-12 With Veledimex in Combination With Nivolumab in Subjects With Glioblastoma; a Substudy to ATI001-102

IA Carboplatin + Radiotherapy in Relapsing GBM

PH Sensitive MRI Based Resections of Glioblastoma

Feasibility of ONCOhabitats for Surgical and Treatment Planning in IDH-Wildtype Glioblastoma (SINUE)

Multi-Dimensional MRI Spatial Heterogeneity Analysis for Predicting Key Genes and Prognosis of High-Grade Gliomas: A Multi-Center Study

ERP-Based Research on the Modulation of Remimazolam on Working Memory and Brain Network Mechanisms in Glioma Patients

RENEW: Feasibility of CMV RNA-Pulsed Dendritic Cells Vaccines for the Treatment of Newly Diagnosed Glioblastoma Patients.

Radiolabeled TSPO Targeted Molecular Probe in Glioma

Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker

Vemurafenib in Children With Recurrent/Refractory BRAF Gene V600E (BRAFV600E)-Mutant Gliomas

Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma